Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy

First-line chemotherapy to combat primary malignant brain cancer is often accompanied by lymphopenic immunologic deficiency. Although counterintuitive, chemotherapy-induced lymphopenia can provide excellent host conditioning that may actually be leveraged to potentiate antitumor immunotherapy. We di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Sanchez-Perez, Luis, Suryadevara, Carter M, Choi, Bryan D, Reap, Elizabeth A, Sampson, John H
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Author's View
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292586/
https://ncbi.nlm.nih.gov/pubmed/25610727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.944054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars